SCHEMBL23516097

SCHEMBL23516097

CN1C(=O)c2cccc(-n3c4ccccc4c4cc(-c5ccncc5)ccc43)c2C1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK14 Q16539 4/20 0.41
▸ ROCK2 O75116 3/20 0.39
▸ METAP2 P50579 4/20 0.36
▸ NPY5R Q15761 1/20 0.36
▸ NR4A2 P43354 1/20 0.35
▸ PIK3CD O00329 1/20 0.35
▸ PIK3CA P42336 1/20 0.35
▸ PIK3CB P42338 1/20 0.35
▸ MTOR P42345 1/20 0.35
▸ PIK3CG P48736 1/20 0.35
▸ CDC7 O00311 1/20 0.34
▸ MAP4K4 O95819 1/20 0.34
▸ PRKACA P17612 1/20 0.34
▸ CDK2 P24941 1/20 0.34
▸ GSK3B P49841 1/20 0.34
▸ CLK4 Q9HAZ1 1/20 0.34
▸ IRAK4 Q9NWZ3 1/20 0.34
▸ DUSP3 P51452 1/20 0.34
▸ BRD4 O60885 1/20 0.34
▸ CASP3 P42574 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23516095 0.96 ROCK2 (0.39) MAPK14ROCK2METAP2NR4A2PIK3CD
SCHEMBL23516356 0.94 MAPK14 (0.41) MAPK14ROCK2METAP2CDC7MAP4K4
SCHEMBL23516508 0.89 CYP11B2 (0.43) MAPK14METAP2NR4A2MAP4K4PRKACA
SCHEMBL19852617 0.89 MEN1 (0.36) NPY5RDUSP3BRD4CASP3
SCHEMBL23516094 0.89 METAP2 (0.43) ROCK2METAP2PIK3CDPIK3CAPIK3CB
SCHEMBL23515907 0.86 DUSP3 (0.42) MAPK14ROCK2DUSP3BRD4CASP3
SCHEMBL23516312 0.85 BRD4 (0.38) BRD4CASP3
SCHEMBL23515994 0.85 HSPA1A (0.41) MAPK14PIK3CA
SCHEMBL19848894 0.85 METAP2 (0.40) MAPK14METAP2NPY5RIRAK4BRD4
SCHEMBL23516502 0.85 PDE10A (0.39) NPY5RGSK3BCLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11276825-B2 Organic molecules for use in organic devices CYNORA GMBH (DE) 2022-03-15 — — US disclosed
US-20210184134-A1 ORGANIC MOLECULES FOR USE IN ORGANIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2021-06-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210184134-A1 ORGANIC MOLECULES FOR USE IN ORGANIC DEVICES CHRM1, C1S, DNMT3L MAPK14 2770/4885ROCK2 747/4885METAP2 3053/4885
US-11276825-B2 Organic molecules for use in organic devices AOX1, OR10J3, L1CAM MAPK14 3910/4885ROCK2 439/4885METAP2 3608/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback